DOC vs SBAC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
DOC
51.5
AI Score
VS
DOC Wins
SBAC
38.0
AI Score
Investment Advisor Scores
SBAC
38score
Recommendation
SELL
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | DOC | SBAC | Winner |
|---|---|---|---|
| Revenue | 2.35B | 2.13B | DOC |
| Net Income | 263.71M | 614.92M | SBAC |
| Net Margin | 11.2% | 28.8% | SBAC |
| ROE | 3.4% | -12.7% | DOC |
| ROA | 1.2% | 5.3% | SBAC |
| Total Assets | 22.41B | 11.62B | DOC |
| Cash | 514.31M | 417.53M | DOC |
| Debt/Equity | 1.19 | -2.67 | SBAC |
Relative Price Performance (Last 90 Days)
DOC 1M: +7.7%
· 3M: -1.2%
SBAC 1M: +3.9%
· 3M: +4.6%
Current Technical Phase
DOC
NeutralHold
Mixed signals - no dominant trend phase, RSI 61
SBAC
NeutralHold
Mixed signals - no dominant trend phase, RSI 60
Fundamentals Snapshot
| Metric | DOC | SBAC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 145.8 | 24.2 |
| Trailing P/E | 37.5 | 20.6 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.6% | 0.7% |
| Operating Margin | 0.1% | 0.5% |
| EPS | 0.55 | 9.26 |
| Dividend Yield | 0.06% | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, DOC is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.